ivomec vet 10 mg/ml injektioneste, liuos
boehringer ingelheim animal health nordics a/s - ivermectin - injektioneste, liuos - 10 mg/ml - ivermektiini
lidocard 20 mg/ml injektio-/infuusioneste, liuos
orion corporation orion pharma - lidocaine hydrochloride monohydrate - injektio-/infuusioneste, liuos - 20 mg/ml - lidokaiini
losec mups 20 mg enterotabletti
orifarm oy - omeprazole magnesium - enterotabletti - 20 mg - omepratsoli
hydrocortison 1 % emulsiovoide
orion corporation - hydrocortisone - emulsiovoide - 1 % - hydrokortisoni
fludara 10 mg tabletti, kalvopäällysteinen
genzyme europe b.v. - fludarabine fosfate - tabletti, kalvopäällysteinen - 10 mg - fludarabiini
genotropin 4 iu/1.3 mg injektiokuiva-aine
pfizer health ab - somatropinum - injektiokuiva-aine - 4 iu/1.3 mg - somatropiini
azithrom 250 mg tabletti, kalvopäällysteinen
hexal ag - azithromycinum dihydricum - tabletti, kalvopäällysteinen - 250 mg - atsitromysiini
pemazyre
incyte biosciences distribution b.v. - pemigatinib - cholangiocarcinoma - antineoplastiset aineet - pemazyre monotherapy is indicated for the treatment of adults with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.